This information is for educational purposes only. It is not intended as medical advice. Always consult a qualified healthcare professional.
OTC
Orfadin
INN: nitisinone
Data updated: 2026-05-28
Available in:
🇨🇿🇩🇪🇬🇧🇫🇷🇷🇺🇸🇰
Form
—
Dosage
—
Route
—
Storage
—
About This Product
Manufacturer
User Reviews
Reviews reflect personal experiences and are not medical advice. Always consult your doctor.
Swedish Orphan Biovitrum International AB
ATC Code
A16AX04
Source
EMA · EMEA/H/C/000555
USDailyMed:Nitisinone
A16AX04(WHO)
CA:℞-onlyUS:℞-onlyEU:Rx-only
2-[2-nitro-4-(trifluoromethyl)benzoyl]cyclohexane-1,3-dione
104206-65-7Y
115355
6834
DB00348Y
103195Y
K5BN214699
D05177Y
CHEBI:50378Y
ChEMBL1337Y
DTXSID9042673
Interactive image
O=C(c1ccc(cc1[N+]([O-])=O)C(F)(F)F)C2C(=O)CCCC2=O
InChI=1S/C14H10F3NO5/c15-14(16,17)7-4-5-8(9(6-7)18(22)23)13(21)12-10(19)2-1-3-11(12)20/h4-6,12H,1-3H2YKey:OUBCNLGXQFSTLU-UHFFFAOYSA-NY
Nitisinone, sold under the brand nameOrfadinamong others, is amedicationused for the treatment ofhereditary tyrosinemia type 1;or for the reduction of urinehomogentisic acidin adults withalkaptonuria.Nitisinone is ahydroxyphenyl-pyruvate dioxygenaseinhibitor.
It is available as ageneric medication.
⚠️ Warnings
• Caution should be exercised in patients with history of metabolic disorder, any allergy, who are taking other medications, during pregnancy and breastfeeding.
• Follow proper diet program as per your healthcare provider’s advice.
• Monitor sugar level regularly for diabetic patients during the treatment.
• Monitor blood cell counts, vision tests, liver function tests and blood phosphate or tyrosine levels regularly while taking this medication.